INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.95 Cr | ₹-15 Cr | ₹3.80 Cr | ₹1.84 Cr | ₹1.93 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INNOVA CAPTAB ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.95 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹3.80 Cr |
| Mar2022 | ₹1.84 Cr |
| Mar2021 | ₹1.93 Cr |
How is Deferred Tax Assets / Liabilities of INNOVA CAPTAB Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.95 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹3.80 Cr | 106.91 | |
| Mar2022 | ₹1.84 Cr | -4.62 | |
| Mar2021 | ₹1.93 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,872.4 Cr | 7.7% | -2.3% | -29.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 7.7% |
-2.3% |
-29.6% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses